At embecta (formerly part of BD), we are singularly focused on improving the lives of people living with diabetes. With a 100-year legacy of developing and providing solutions to the diabetes community, today, we are a global medical technology company and leader in insulin delivery devices. More than 30 million people in over 100 countries rely on our pen needle and syringe products every day. BD is the manufacturer of the advertised products. Privacy Policy: https://www.embecta.com/en-us/about/policies/privacy-policy-statement
| Website | https://www.embecta.com/ |
| Revenue | $1.1 billion |
| Employees | 1,158 (859 on RocketReach) |
| Founded | 2022 |
| Phone | +1 201-847-6800 |
| Industry | Medical Devices |
| Keywords | Diabetes Care, Diabetes Management, Diabetes Treatment, Diabetes Technology, Diabetes Solutions, Insulin Delivery, Diabetes Supplies, Diabetes Prevention, Glucose Monitoring, Insulin Pumps, Diabetes Testing, Medical Devices, Blood Glucose Meters, Medical Technology, Patient Care, Endocrine Care, Healthcare Technology, Health Monitoring, Remote Patient Monitoring |
| Competitors | Roche, Medtronic, Abbott, The Janssen Pharmaceutical Companies of Johnson & Johnson, Novo Nordisk, BD, Dexcom, Insulet Corporation, LifeScan, Ypsomed AG +27 more (view full list) |
Looking for a particular embecta employee's phone or email?
The embecta annual revenue was $1.1 billion in 2026.
Leisha Ayres is the CIO and Head of Shared Services of embecta.
859 people are employed at embecta.